Autologous inclusion technique versus Dacron inclusion technique in modified Ross surgery in adults: a retrospective single-center study

The Ross procedure has been shown to have excellent long-term outcomes. However, pulmonary autografts remain at risk of dilation in the long-term period. Therefore, the autologous inclusion technique (AIT) and the Dacron inclusion technique (DIT) have been developed. No direct comparison up to date has been reported of these two techniques.

Aim: To compare immediate and medium-term results performing various modified techniques of the Ross operation.

Material and Methods. The following retrospective study included 43 patients (AIT: 22; DIT: 21) aged 18 years and older with an aortic valve (AV) pathology who underwent modified Ross procedures (AIT and DIT) from January 2014 to December 2019, performed by a single surgeon. The main endpoints were: in-hospital mortality, postoperative AV pressure gradients, time of myocardial ischemia and cardiopulmonary bypass, postoperative complications (resternotomy due to bleeding, perioperative myocardial infarction, stroke, sternal infection, conduction disorder requiring implantation of a permanent pacemaker, acute renal failure requiring hemodialysis) and mid-term outcomes (freedom from reoperation, freedom from aortic dilatation ≥ 5 cm). The median follow-up period was 23 (12–68) months.

Results. The main indication for surgery was aortic regurgitation in 32 patients (74.4%). Bicuspid aortic valve was diagnosed in 29 (67.4%) patients. There were 33 (76.7%) males with an average age of 40 ± 11.7 years. There were no lethal outcomes in both groups. There was also no significant difference in postoperative complications. The peak and mean gradients on the AV were significantly lower in the AIT group than in the DIT group (6 and 4 mmHg vs 8 and 7 mmHg, p = 0.04). Five-year overall survival, freedom from reoperation on AV and PV, and freedom from dilatation of the ascending aorta ≥ 5 cm after modified Ross operation were 97.4%, 100%, and 100%, respectively. There was no statistically significant difference between groups in terms of overall survival (p = 0.66).

Conclusion. Both techniques, autologous inclusion and Dacron inclusion, provide excellent immediate and mid-term outcomes in terms of overall survival, freedom from reoperation and freedom from aortic dilation

1. Baumgartner H., Falk V, Bax J.J., De Bonis M., Hamm C., Holm P.J. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2017;38(36):2739–2791. DOI: 10.1093/eurheartj/ehx391.

2. Ross D.N. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet (London, England). 1967;2(7523):956–958. DOI: 10.1016/s0140-6736(67)90794-5.

3. El-Hamamsy I., Eryigit Z., Stevens L.-M., Sarang Z., George R., Clark L. et al. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet (London, England). 2010;376(9740):524–531. DOI: 10.1016/S0140-6736(10)60828-8.

4. Tsaroev B., Chernov I., Enginoev S., Mustaev M. Survival and freedom from reoperation after the Ross procedure in a Russian adult population: A single-center experience. JTCVS Open. 2022;10:140–147. DOI: 10.1016/j.xjon.2022.04.026.

5. Gofus J., Fila P., Drabkova S., Zacek P., Ondrasek J., Nemec P. et al. Ross procedure provides survival benefit over mechanical valve in adults: a propensity-matched nationwide analysis. Eur. J. Cardio-Thoracic. Surg. 2022;61:1357–1365. DOI: 10.1093/ejcts/ezac013.

6. El-Hamamsy I., Toyoda N., Itagaki S., Stelzer P., Varghese R., Williams E.E. et al. Propensity-matched comparison of the Ross procedure and prosthetic aortic valve replacement in adults. J. Am. Coll. Cardiol. 2022;79:805–815. DOI: 10.1016/j.jacc.2021.11.057.

7. Brown J.W., Ruzmetov M., Rodefeld M.D., Mahomed Y., Turrentine M.W. Incidence of and risk factors for pulmonary autograft dilation after Ross aortic valve replacement. Ann. Thorac. Surg. 2007;83(5):1781–1789. DOI: 10.1016/j.athoracsur.2006.12.066.

8. Kouchoukos N.T., Masetti P., Nickerson N.J., Castner C.F., Shannon W.D., Dávila-Román V.G. The Ross procedure: long-term clinical and echocardiographic follow-up. Ann. Thorac. Surg. 2004;78(3):773–781. DOI: 10.1016/j.athoracsur.2004.02.033.

9. David T.E., Omran A., Ivanov J., Armstrong S., de Sa M.P., Sonnenberg B. et al. Dilation of the pulmonary autograft after the Ross procedure. J. Thorac. Cardiovasc. Surg. 2000;119(2):210–220. DOI: 10.1016/S00225223(00)70175-9.

10. Chernov I.I., Enginoev S.T., Kondrat’ev D.A., Zenkov A.A., Abdurakhmanov A.A., Tarasov D.G. The David procedure after the Ross operation: case series. Russian Journal of Cardiology. 2021;26(S4):4767. (In Russ.). DOI: 10.15829/1560-4071-2021-4767.

11. Skillington P.D., Mokhles M.M., Takkenberg J.J.M., Larobina M., O’Keefe M., Wynne R. et al. The Ross procedure using autologous support of the pulmonary autograft: Techniques and late results. J. Thorac. Cardiovasc. Surg. 2015;149(2 Suppl.):S46–S52. DOI: 10.1016/j.jtcvs.2014.08.068.

12. Chernov I.I., Enginoev S.T., Kondratyev D.A., Kozmin D.Yu., Demetskaya V.V., Aliev E.R. et al. Five-year outcomes of the modified Ross surgery in adults: experience from one center. Circulation Pathology and Cardiac Surgery. 2021;25(3):43–50. (In Russ.). DOI: 10.21688/16813472-2021-3-43-50.

13. Carrel T., Kadner A. Long-term clinical and imaging follow-up after reinforced pulmonary autograft Ross procedure. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 2016;19(1):59–62. DOI: 10.1053/j.pcsu.2015.11.005.

14. Mazine A., El-Hamamsy I., Verma S., Peterson M.D., Bonow R.O., Yacoub M.H. et al. Ross procedure in adults for cardiologists and cardiac surgeons: JACC state-of-the-art review. J. Am. Coll. Cardiol. 2018;72(22):2761–2777. DOI: 10.1016/j.jacc.2018.08.2200.

15. Flynn C.D., Bono J.H. De, Muston B., Rattan N., Tian D.H., Larobina M. et al. Systematic review and meta-analysis of long-term outcomes in adults undergoing the Ross procedure. Ann. Cardiothorac. Surgery. 2021;10(4):411–419. DOI: 10.21037/acs-2021-rp-30.

16. Luciani G.B., Mazzucco A. Aortic root disease after the Ross procedure. Curr. Opin. Cardiol. 2006;21(5):555–560. DOI: 10.1097/01.hco.0000245742.93453.1d.

17. Juthier F., Banfi C., Vincentelli A., Ennezat P.-V., Le Tourneau T., Pinçon C. et al. Modified Ross operation with reinforcement of the pulmonary autograft: Six-year results. J. Thorac. Cardiovasc. Surg. 2010;139:1420–1423. DOI: 10.1016/j.jtcvs.2010.01.032.

18. Al Rashidi F., Bhat M., Höglund P., Meurling C., Roijer A., Koul B. The modified Ross operation using a Dacron prosthetic vascular jacket does prevent pulmonary autograft dilatation at 4.5-year follow-up. Eur. J. Cardio-Thoracic. Surg. 2010;37(4):928–933. DOI: 10.1016/j.ejcts.2009.11.008.

19. Chauvette V., Chamberland M.-È., El-Hamamsy I. A review of pulmonary autograft external support in the Ross procedure. Expert Rev. Med. Devices. 2019;16(11):981–988. DOI: 10.1080/17434440.2019.1685380.